Trajan Wealth LLC Buys 28,276 Shares of The Cooper Companies, Inc. $COO

Trajan Wealth LLC increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 15.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 207,545 shares of the medical device company’s stock after acquiring an additional 28,276 shares during the period. Trajan Wealth LLC’s holdings in Cooper Companies were worth $17,010,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in COO. Bell Investment Advisors Inc grew its position in Cooper Companies by 106.3% in the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC bought a new position in Cooper Companies in the second quarter valued at $36,000. True Wealth Design LLC grew its position in Cooper Companies by 484.8% in the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after purchasing an additional 383 shares in the last quarter. Cromwell Holdings LLC grew its position in Cooper Companies by 128.8% in the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after purchasing an additional 273 shares in the last quarter. Finally, Board of the Pension Protection Fund bought a new position in Cooper Companies in the fourth quarter valued at $41,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO stock opened at $61.75 on Thursday. The stock has a market cap of $12.05 billion, a P/E ratio of 30.57, a P/E/G ratio of 1.58 and a beta of 0.89. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The company has a fifty day moving average price of $67.37 and a two-hundred day moving average price of $75.28. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on COO. Citigroup decreased their target price on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research report on Friday, March 6th. William Blair raised shares of Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Rothschild & Co Redburn downgraded shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a research report on Wednesday, March 4th. Needham & Company LLC raised their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research report on Friday, March 6th. Finally, Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.